Biosynthesis of Hibarimicins. III. Structures of New Hibarimicin-related Metabolites Produced by Blocked Mutants
Overview
Pharmacology
Authors
Affiliations
Structures of metabolites produced by blocked mutants of Microbispora rosea subsp. hibaria TP-A0121, hibarimicin-producer, were determined by spectroscopic analysis. HMP-Y6 is the dimer of the west half of hibarimicin B, the aglycon of which is the genuine biosynthetic intermediate. HMP-P1 is the shunt product arising from the release of a methanol molecule from hibarimicinone. HMP-P4, the glycoside of HMP-P1, is glycosylated with two amicetoses and two digitoxoses same as hibarimicin B. HMP-M1, M2, M3 and M4 are shunt products derived from the monomeric undecaketide intermediates.
Li K, Guo Z, Bai L Synth Syst Biotechnol. 2024; 9(4):701-712.
PMID: 38868608 PMC: 11167396. DOI: 10.1016/j.synbio.2024.05.012.
Synthetic studies directed toward the AB decalin common to HMP-Y1 and hibarimicinone.
Hempel J, Engers D, Sulikowski G Tetrahedron Lett. 2020; 55(13):2157-2159.
PMID: 32855575 PMC: 7449242. DOI: 10.1016/j.tetlet.2014.02.069.
Studies on a biomimetic oxidative dimerization approach to the hibarimicins.
Romaine I, Sulikowski G Tetrahedron Lett. 2015; 56(23):3617-3619.
PMID: 26236055 PMC: 4518470. DOI: 10.1016/j.tetlet.2015.01.127.
A comprehensive review of glycosylated bacterial natural products.
Elshahawi S, Shaaban K, Kharel M, Thorson J Chem Soc Rev. 2015; 44(21):7591-697.
PMID: 25735878 PMC: 4560691. DOI: 10.1039/c4cs00426d.
Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.
Liau B, Milgram B, Shair M J Am Chem Soc. 2012; 134(40):16765-72.
PMID: 22970979 PMC: 3468709. DOI: 10.1021/ja307207q.